nefazodone has been researched along with Briquet Syndrome in 2 studies
nefazodone: may be useful as an opiate adjunct
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nefazodone is an antidepressant medication which received approval from the Food and Drug Administration for treatment of major depressive disorder in 1994." | 4.80 | The antidepressant nefazodone. A review of its pharmacology, clinical efficacy, adverse effects, dosage, and administration. ( Khouzam, HR, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khouzam, HR | 1 |
| Menza, M | 1 |
| Lauritano, M | 1 |
| Allen, L | 1 |
| Warman, M | 1 |
| Ostella, F | 1 |
| Hamer, RM | 1 |
| Escobar, J | 1 |
1 review available for nefazodone and Briquet Syndrome
| Article | Year |
|---|---|
The antidepressant nefazodone. A review of its pharmacology, clinical efficacy, adverse effects, dosage, and administration.
Topics: Antidepressive Agents, Second-Generation; Biological Availability; Depressive Disorder; Dose-Respons | 2000 |
1 trial available for nefazodone and Briquet Syndrome
| Article | Year |
|---|---|
Treatment of somatization disorder with nefazodone: a prospective, open-label study.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Female; Humans; Male; Middle Aged; Pilot Proj | 2001 |